PHARMACEUTICAL SECTOR AND ECONOMY: A BIBLIOMETRIC ANALYSIS
Main Article Content
Keywords
drug industry, article, human, economic aspect, pharmaceutical industry
Abstract
The purpose of this research work is to evaluate the evolution of the economy in pharmaceutical companies; determine the thematic axes and identify the co-citation networks between authors, documents and sources of literature on the economy in intersection with the pharmaceutical industry. A descriptive study was carried out with bibliometric indicators and visualization maps, in which the Scopus database of the documents included from 2013 to 2023 was used. 129 records that met the inclusion criteria were considered, 89 research articles, 4 conference papers, 11 reviews and others, in addition to being filtered by the languages of English and Spanish. When talking about the results of the research carried out, the authors Harrison C stand out with 3 publications and Antunes Ams with 2. Although there are many to talk about in the journals and affiliations, only two of each have been highlighted. . On the journal side, Sustainability (Switzerland) and Systematic Reviews In Pharmacy were found with 4 and 3 publications, respectively. Finally, regarding affiliations, the University Of Chittagong with 9 and the Kafrelsheikh University with 8 publications each were obtained as references.
References
1. Abhayawansa, S., & Azim, M. (2014). Corporate reporting of intellectual capital: evidence from the Bangladeshi pharmaceutical sector. Asian Review of Accounting, 22(2), 98–127. https://doi.org/10.1108/ara-10-2013-0067
2. Abraham, J. (2023). Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. Routledge. https://doi.org/10.4324/9781003421405
3. Ahmad, M., Allen, M. M. C., Raziq, M. M., & ur Rehman, W. (2019). Converging HRM practices? A comparison of high performance work system practices in MNC subsidiaries and domestic firms in Pakistan. Employee Relations: The International Journal, 41(5), 931–948. https://doi.org/10.1108/er-01-2018-0021
4. Ahmed, R. R., Kyriakopoulos, G. L., Streimikiene, D., & Streimikis, J. (2021). Drivers of proactive environmental strategies: Evidence from the pharmaceutical industry of Asian economies. Sustainability, 13(16), 9479. https://doi.org/10.3390/su13169479
5. Alnajem, M., Mostafa, M. M., & ElMelegy, A. R. (2021). Mapping the first decade of circular economy research: a bibliometric network analysis. Journal of Industrial and Production Engineering, 38(1), 29-50. https://doi.org/10.1080/21681015.2020.1838632
6. AlRuthia, Y., Alsenaidy, M. A., Alrabiah, H. K., AlMuhaisen, A., & Alshehri, M. (2018). The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective. Human Resources for Health, 16(1). https://doi.org/10.1186/s12960-018-0294-8
7. Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, 28(2), 799-805. https://doi.org/10.1007/s40199-020-00358-5
8. Ayyolath, A., Kallingal, A., Thachan Kundil, V., & Variyar, E. J. (2020). Studies on the bioactive properties of Penicillium mallochi ARA-1 pigment isolated from coffee plantation. Biocatalysis and Agricultural Biotechnology, 30(1), 101841. https://doi.org/10.1016/j.bcab.2020.101841
9. Azelee, N. I. W., Digvijay, D., Ayothiraman, S., Noor, N. M., Abd Rasid, Z. I., Ramli, A. N. M., ... & Selvasembian, R. (2023). Sustainable valorization approaches on crustacean wastes for the extraction of chitin, bioactive compounds and their applications-A review. International journal of biological macromolecules, 253(2), 126492. https://doi.org/10.1016/j.ijbiomac.2023.126492
10. Barbieri, E., Huang, M., Pi, S., & Tassinari, M. (2017). Restructuring the Production of Medicines: An Investigation on the Pharmaceutical Sector in China and the Role of Mergers and Acquisitions. International Journal of Environmental Research and Public Health, 14(10), 1179. https://doi.org/10.3390/ijerph14101179
11. Bhatia, P., & Chugh, A. (2015). Role of marine bioprospecting contracts in developing access and benefit sharing mechanism for marine traditional knowledge holders in the pharmaceutical industry. Global Ecology and Conservation, 3(1), 176–187. https://doi.org/10.1016/j.gecco.2014.11.015
12. Birch, K., Levidow, L., & Papaioannou, T. (2012). Self-Fulfilling Prophecies of the European Knowledge-Based Bio-Economy: The Discursive Shaping of Institutional and Policy Frameworks in the Bio-Pharmaceuticals Sector. Journal of the Knowledge Economy, 5(1), 1–18. https://doi.org/10.1007/s13132-012-0117-4
13. Buick, A. (2023). Intellectual Property Rights in Pharmaceutical Test Data: Origins, Globalisation and Impact. Springer Nature. https://doi.org/10.1007/978-3-031-29436-5
14. Chahal, H., Dangwal, R., & Raina, S. (2014). Conceptualisation, development and validation of green marketing orientation (GMO) of SMEs in India. Journal of Global Responsibility, 5(2), 312–337. https://doi.org/10.1108/jgr-02-2014-0005
15. Chaudhary, P., Singh, D., Swapnil, P., Meena, M., & Janmeda, P. (2023). Euphorbia neriifolia (Indian Spurge Tree): A plant of multiple biological and pharmacological activities. Sustainability, 15(2), 1225. https://doi.org/10.3390/su15021225
16. Chomać-Pierzecka, E. (2023). Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management. Sustainability, 15(11), 8889. https://doi.org/10.3390/su15118889
17. Chowdhury, L. A. M., Rana, T., & Azim, M. I. (2019). Intellectual capital efficiency and organisational performance. Journal of Intellectual Capital, 20(6), 784–806. https://doi.org/10.1108/jic-10-2018-0171
18. Daemmrich, A., & Mohanty, A. (2014). Healthcare reform in the United States and China: pharmaceutical market implications. Journal of Pharmaceutical Policy and Practice, 7(1), 1-9. https://doi.org/10.1186/2052-3211-7-9
19. Di Tommaso, M. R., Spigarelli, F., Barbieri, E., & Rubini, L. (2020). The Globalization of China’s Health Industry: Industrial Policies, International Networks and Company Choices. Springer Nature. https://dx.doi.org/10.1007/978-3-030-46671-8
20. Dorta-González, P., & Dorta-González, M. I. (2010). Indicador bibliométrico basado en el índice h. Revista Española de Documentación Científica, 33(2), 225-245. https://doi.org/10.3989/redc.2010.2.733
21. Dunne, N. (2020). Public Interest and EU Competition Law. The Antitrust Bulletin, 0003603X2091288. https://doi.org/10.1177/0003603x20912883
22. ElNaggar, M. H., Elgazar, A. A., Gamal, G., Hamed, S. M., Elsayed, Z. M., El-Ashrey, M. K., ... & Eldehna, W. M. (2023). Identification of sulphonamide-tethered N-((triazol-4-yl) methyl) isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of enzyme inhibition and medicinal chemistry, 38(1), 2234665. https://doi.org/10.1080/14756366.2023.2234665
23. Geiger, C. (n.d.). The rise of criminal enforcement of intellectual property rights…and its failure in the context of copyright infringements on the Internet. The Evolution and Equilibrium of Copyright in the Digital Age, 113–142. https://doi.org/10.1017/cbo9781107477179.009
24. Grimes, S., & Miozzo, M. (2015). Big Pharma’s Internationalization of R&D to China. European Planning Studies, 23(9), 1873–1894. https://doi.org/10.1080/09654313.2015.1029443
25. Harrison, C., Burnard, K., & Paul, S. (2018). Entrepreneurial leadership in a developing economy: a skill-based analysis. Journal of Small Business and Enterprise Development, 25(3), 521–548. https://doi.org/10.1108/jsbed-05-2017-0160
26. Harrison, C., Paul, S., & Burnard, K. (2016). Entrepreneurial leadership in retail pharmacy: developing economy perspective. Journal of Workplace Learning, 28(3), 150–167. https://doi.org/10.1108/jwl-01-2015-0004
27. Hossain, M. S., Sharifuzzaman, S. M., Nobi, M. N., Chowdhury, M. S. N., Sarker, S., Alamgir, M., … Chowdhury, S. (2021). Seaweeds farming for sustainable development goals and blue economy in Bangladesh. Marine Policy, 128(1), 104469. https://doi.org/10.1016/j.marpol.2021.104469
28. Hosseini-Motlagh, S.-M., Nami, N., & Farshadfar, Z. (2020). Collection disruption management and channel coordination in a socially concerned closed-loop supply chain: A game theory approach. Journal of Cleaner Production, 276(1), 124173. https://doi.org/10.1016/j.jclepro.2020.124173
29. Hu, Y., Scherngell, T., Man, S. N., & Wang, Y. (2013). Is the United States Still Dominant in the Global Pharmaceutical Innovation Network? PLoS ONE, 8(11), e77247. https://doi.org/10.1371/journal.pone.0077247
30. Ibrahim, M. I. M., & Wertheimer, A. I. (2018). Introduction. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries, 1–11. https://doi.org/10.1016/b978-0-12-811228-1.00001-7
31. Janes, K. A., Chandran, P. L., Ford, R. M., Lazzara, M. J., Papin, J. A., Peirce, S. M., … Lauffenburger, D. A. (2017). An engineering design approach to systems biology. Integrative Biology, 9(7), 574–583. https://doi.org/10.1039/c7ib00014f
32. Kohli, M., & Gill, S. (2019). Impact of family involvement on strategy and CEO compensation. Journal of Family Business Management, 10(3), 189–212. https://doi.org/10.1108/jfbm-09-2019-0060
33. Kumar, A., Zavadskas, E. K., Mangla, S. K., Agrawal, V., Sharma, K., & Gupta, D. (2018). When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry. International Journal of Production Research, 1–23. https://doi.org/10.1080/00207543.2018.1543969
34. Lakner, Z., Kiss, A., Popp, J., Zéman, Z., Máté, D., & Oláh, J. (2019). From Basic Research to Competitiveness: An Econometric Analysis of the Global Pharmaceutical Sector. Sustainability, 11(11), 3125. https://doi.org/10.3390/su11113125
35. Limas Suárez, S. J. (2018). El sector farmacéutico, eje de desarrollo estratégico. Una perspectiva desde el ámbito local. Innovar, 28(69), 149–174. https://doi.org/10.15446/innovar.v28n69.71733
36. Lucarini, M., Durazzo, A., Romani, A., Campo, M., Lombardi-Boccia, G., & Cecchini, F. (2018). Bio-Based Compounds from Grape Seeds: A Biorefinery Approach. Molecules, 23(8), 1888. https://doi.org/10.3390/molecules23081888
37. Marques, C. M., Moniz, S., de Sousa, J. P., Barbosa-Povoa, A. P., & Reklaitis, G. (2020). Decision-support challenges in the chemical-pharmaceutical industry: Findings and future research directions. Computers & Chemical Engineering, 134(1), 106672. https://doi.org/10.1016/j.compchemeng.2019.106672
38. McKinlay, J. B. (Ed.). (2022). Issues in the political economy of health care (Vol. 25). Routledge. https://books.google.es/books?id=gAJlEAAAQBAJ&lr=&hl=es&source=gbs_navlinks_s
39. Milanesi, M., Runfola, A., & Guercini, S. (2020). Pharmaceutical industry riding the wave of sustainability: Review and opportunities for future research. Journal of cleaner production, 261(1), 121204. https://doi.org/10.1016/j.jclepro.2020.121204
40. Monteiro, A. R., Battisti, A. P., Valencia, G. A., & de Andrade, C. J. (2023). The production of high-added-value bioproducts from non-conventional biomasses: An overview. Biomass, 3(2), 123-137. https://doi.org/10.3390/biomass3020009
41. Mussagy, C. U., & Dufossé, L. (2023). A review of natural astaxanthin production in a circular bioeconomy context using Paracoccus carotinifaciens. Bioresource Technology, 369(1), 128499. https://doi.org/10.1016/j.biortech.2022.128499
42. Naeem, M. Y., Corbo, F., Crupi, P., & Clodoveo, M. L. (2023). Hemp: An alternative source for various industries and an emerging tool for functional food and pharmaceutical sectors. Processes, 11(3), 718. https://doi.org/10.3390/pr11030718
43. Nguyen, T. A., Vitry, A., & Roughead, E. E. (2017). Pharmaceutical Policy in Vietnam. Pharmaceutical Policy in Countries with Developing Healthcare Systems, 75–94. https://doi.org/10.1007/978-3-319-51673-8_5
44. Niebles-Nunez, W., Ramirez, J., & Garcia-Tirado, J. (2022). International Trade between Colombia and Asia in the Framework of Logistics Processes: A Bibliometric Review. Journal of Distribution Science, 20(10), 39-50. https://n9.cl/z77hed
45. Pai, S., Hebbar, A., & Selvaraj, S. (2022). A critical look at challenges and future scopes of bioactive compounds and their incorporations in the food, energy, and pharmaceutical sector. Environmental Science and Pollution Research, 29(24), 35518-35541. https://doi.org/10.1007/s11356-022-19423-4
46. Purkayastha, S., Manolova, T. S., & Edelman, L. F. (2015). Business Group Effects on the Innovation-Internationalization Relationship: Evidence from the Indian Pharmaceutical Sector. Advances in International Management, 379–402. https://doi.org/10.1108/s1571-502720150000028017
47. Ramirez, J., Gallego, G., Ez, W. N. N. N., & Tirado, J. G. (2023). Blockchain Technology for Sustainable Supply Chains: A Bibliometric Study. Journal of Distribution Science, 21(6), 119-129. https://doi.org/10.15722/jds.21.06.202306.119
48. Ramírez-Duran, J. A., Niebles-Núñez, W., & García-Tirado, J. (2023). Aplicaciones bibliométricas del estudio del capital intelectual dentro de las instituciones de educación superior desde un enfoque sostenible. Saber, Ciencia y Libertad, 18(1). https://n9.cl/2ofg4
49. Ramy, A., Af Ragab, M., & Arisha, A. (2020). Knowledge management in the pharmaceutical industry between academic research and industry regulations. Knowledge Management Research & Practice, 1–17. https://doi.org/10.1080/14778238.2020.1767517
50. Romani, A., Campo, M., Urciuoli, S., Marrone, G., Noce, A., & Bernini, R. (2020). An Industrial and Sustainable Platform for the Production of Bioactive Micronized Powders and Extracts Enriched in Polyphenols From Olea europaea L. and Vitis vinifera L. Wastes. Frontiers in Nutrition, 7(1). https://doi.org/10.3389/fnut.2020.00120
51. Sabat, K. C., Bhattacharyya, S. S., & Krishnamoorthy, B. (2022). Circular economy in pharmaceutical industry through the lens of stimulus organism response theory. European Business Review, 34(6), 936-964. https://doi.org/10.1108/EBR-02-2022-0037
52. Scott, P., & Walker, J. T. (2017). Retailing under resale price maintenance: Economies of scale and scope, and firm strategic response, in the inter-war British retail pharmacy sector. Business History, 60(6), 807–832. https://doi.org/10.1080/00076791.2017.1340455
53. Sharma, M., Sehrawat, R., Giannakis, M., & Dwivedi, Y. K. (2023). Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector. Annals of operations research, 1-28. https://doi.org/10.1007/s10479-023-05391-6
54. Sharma, S., & Dharni, K. (2017). Intellectual capital disclosures in an emerging economy: status and trends. Journal of Intellectual Capital, 18(4), 868–883. https://doi.org/10.1108/jic-09-2016-0092
55. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., ... & Yang, C. (2021). Drug shortage: causes, impact, and mitigation strategies. Frontiers in pharmacology, 12(1), 693426. https://doi.org/10.3389/fphar.2021.693426
56. Silva, B. C., & Moreira, A. C. (2022). Entrepreneurship and the gig economy: A bibliometric analysis. Cuadernos de Gestión, 22(2), 23-44. http://hdl.handle.net/10810/56543
57. Stek, P. E., & van Geenhuizen, M. S. (2016). The influence of international research interaction on national innovation performance: A bibliometric approach. Technological Forecasting and Social Change, 110(1), 61–70. https://doi.org/10.1016/j.techfore.2015.09.017
58. Subramanian, D., & Zimmermann, B. (2013). Training and capabilities in French firms. International Journal of Manpower, 34(4), 326–344. https://doi.org/10.1108/ijm-05-2013-0093
59. Sun, P., Qu, Z., & Liao, Z. (2018). How and When Do Subnational Institutions Matter for R&D Investment? Evidence From the Chinese Pharmaceutical Sector. IEEE Transactions on Engineering Management, 65(3), 379–391. https://doi.org/10.1109/tem.2018.2793215
60. Sussex, J., Feng, Y., Mestre-Ferrandiz, J., Pistollato, M., Hafner, M., Burridge, P., & Grant, J. (2016). Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom. BMC Medicine, 14(1). https://doi.org/10.1186/s12916-016-0564-z
61. Tennent, K. D., & Gillett, A. G. (2023). How to research in an archive. Handbook of historical methods for management. Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing, 104-120. https://n9.cl/x1z6y
62. Tripathy, S., & Prajapati, V. (2014). Mergers and acquisitions: Trends in Indian pharmaceutical industry. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 14(4), 182–190. https://doi.org/10.1177/1745790415577854
63. Vecino, X., Reig, M., Valderrama, C., & Cortina, J. L. (2021). Ion-Exchange Technology for Lactic Acid Recovery in Downstream Processing: Equilibrium and Kinetic Parameters. Water, 13(11), 1572. https://doi.org/10.3390/w13111572
64. Weqar, F., & Haque, S. I. (2022). The influence of intellectual capital on Indian firms' financial performance. International Journal of Learning and Intellectual Capital, 19(2), 169-188. https://doi.org/10.1504/IJLIC.2022.121249
65. Wouters, O. J., McKee, M., & Luyten, J. (2020). Estimated research and development investment needed to bring a new medicine to market, 2009-2018. Jama, 323(9), 844-853. https://doi.org/10.1001/jama.2020.1166
66. Yadav, P., & Smith, L. (2014). Pharmaceutical Company Strategies and Distribution Systems in Emerging Markets. Encyclopedia of Health Economics, 1–8. https://doi.org/10.1016/b978-0-12-375678-7.01218-9
2. Abraham, J. (2023). Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. Routledge. https://doi.org/10.4324/9781003421405
3. Ahmad, M., Allen, M. M. C., Raziq, M. M., & ur Rehman, W. (2019). Converging HRM practices? A comparison of high performance work system practices in MNC subsidiaries and domestic firms in Pakistan. Employee Relations: The International Journal, 41(5), 931–948. https://doi.org/10.1108/er-01-2018-0021
4. Ahmed, R. R., Kyriakopoulos, G. L., Streimikiene, D., & Streimikis, J. (2021). Drivers of proactive environmental strategies: Evidence from the pharmaceutical industry of Asian economies. Sustainability, 13(16), 9479. https://doi.org/10.3390/su13169479
5. Alnajem, M., Mostafa, M. M., & ElMelegy, A. R. (2021). Mapping the first decade of circular economy research: a bibliometric network analysis. Journal of Industrial and Production Engineering, 38(1), 29-50. https://doi.org/10.1080/21681015.2020.1838632
6. AlRuthia, Y., Alsenaidy, M. A., Alrabiah, H. K., AlMuhaisen, A., & Alshehri, M. (2018). The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective. Human Resources for Health, 16(1). https://doi.org/10.1186/s12960-018-0294-8
7. Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, 28(2), 799-805. https://doi.org/10.1007/s40199-020-00358-5
8. Ayyolath, A., Kallingal, A., Thachan Kundil, V., & Variyar, E. J. (2020). Studies on the bioactive properties of Penicillium mallochi ARA-1 pigment isolated from coffee plantation. Biocatalysis and Agricultural Biotechnology, 30(1), 101841. https://doi.org/10.1016/j.bcab.2020.101841
9. Azelee, N. I. W., Digvijay, D., Ayothiraman, S., Noor, N. M., Abd Rasid, Z. I., Ramli, A. N. M., ... & Selvasembian, R. (2023). Sustainable valorization approaches on crustacean wastes for the extraction of chitin, bioactive compounds and their applications-A review. International journal of biological macromolecules, 253(2), 126492. https://doi.org/10.1016/j.ijbiomac.2023.126492
10. Barbieri, E., Huang, M., Pi, S., & Tassinari, M. (2017). Restructuring the Production of Medicines: An Investigation on the Pharmaceutical Sector in China and the Role of Mergers and Acquisitions. International Journal of Environmental Research and Public Health, 14(10), 1179. https://doi.org/10.3390/ijerph14101179
11. Bhatia, P., & Chugh, A. (2015). Role of marine bioprospecting contracts in developing access and benefit sharing mechanism for marine traditional knowledge holders in the pharmaceutical industry. Global Ecology and Conservation, 3(1), 176–187. https://doi.org/10.1016/j.gecco.2014.11.015
12. Birch, K., Levidow, L., & Papaioannou, T. (2012). Self-Fulfilling Prophecies of the European Knowledge-Based Bio-Economy: The Discursive Shaping of Institutional and Policy Frameworks in the Bio-Pharmaceuticals Sector. Journal of the Knowledge Economy, 5(1), 1–18. https://doi.org/10.1007/s13132-012-0117-4
13. Buick, A. (2023). Intellectual Property Rights in Pharmaceutical Test Data: Origins, Globalisation and Impact. Springer Nature. https://doi.org/10.1007/978-3-031-29436-5
14. Chahal, H., Dangwal, R., & Raina, S. (2014). Conceptualisation, development and validation of green marketing orientation (GMO) of SMEs in India. Journal of Global Responsibility, 5(2), 312–337. https://doi.org/10.1108/jgr-02-2014-0005
15. Chaudhary, P., Singh, D., Swapnil, P., Meena, M., & Janmeda, P. (2023). Euphorbia neriifolia (Indian Spurge Tree): A plant of multiple biological and pharmacological activities. Sustainability, 15(2), 1225. https://doi.org/10.3390/su15021225
16. Chomać-Pierzecka, E. (2023). Pharmaceutical Companies in the Light of the Idea of Sustainable Development—An Analysis of Selected Aspects of Sustainable Management. Sustainability, 15(11), 8889. https://doi.org/10.3390/su15118889
17. Chowdhury, L. A. M., Rana, T., & Azim, M. I. (2019). Intellectual capital efficiency and organisational performance. Journal of Intellectual Capital, 20(6), 784–806. https://doi.org/10.1108/jic-10-2018-0171
18. Daemmrich, A., & Mohanty, A. (2014). Healthcare reform in the United States and China: pharmaceutical market implications. Journal of Pharmaceutical Policy and Practice, 7(1), 1-9. https://doi.org/10.1186/2052-3211-7-9
19. Di Tommaso, M. R., Spigarelli, F., Barbieri, E., & Rubini, L. (2020). The Globalization of China’s Health Industry: Industrial Policies, International Networks and Company Choices. Springer Nature. https://dx.doi.org/10.1007/978-3-030-46671-8
20. Dorta-González, P., & Dorta-González, M. I. (2010). Indicador bibliométrico basado en el índice h. Revista Española de Documentación Científica, 33(2), 225-245. https://doi.org/10.3989/redc.2010.2.733
21. Dunne, N. (2020). Public Interest and EU Competition Law. The Antitrust Bulletin, 0003603X2091288. https://doi.org/10.1177/0003603x20912883
22. ElNaggar, M. H., Elgazar, A. A., Gamal, G., Hamed, S. M., Elsayed, Z. M., El-Ashrey, M. K., ... & Eldehna, W. M. (2023). Identification of sulphonamide-tethered N-((triazol-4-yl) methyl) isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of enzyme inhibition and medicinal chemistry, 38(1), 2234665. https://doi.org/10.1080/14756366.2023.2234665
23. Geiger, C. (n.d.). The rise of criminal enforcement of intellectual property rights…and its failure in the context of copyright infringements on the Internet. The Evolution and Equilibrium of Copyright in the Digital Age, 113–142. https://doi.org/10.1017/cbo9781107477179.009
24. Grimes, S., & Miozzo, M. (2015). Big Pharma’s Internationalization of R&D to China. European Planning Studies, 23(9), 1873–1894. https://doi.org/10.1080/09654313.2015.1029443
25. Harrison, C., Burnard, K., & Paul, S. (2018). Entrepreneurial leadership in a developing economy: a skill-based analysis. Journal of Small Business and Enterprise Development, 25(3), 521–548. https://doi.org/10.1108/jsbed-05-2017-0160
26. Harrison, C., Paul, S., & Burnard, K. (2016). Entrepreneurial leadership in retail pharmacy: developing economy perspective. Journal of Workplace Learning, 28(3), 150–167. https://doi.org/10.1108/jwl-01-2015-0004
27. Hossain, M. S., Sharifuzzaman, S. M., Nobi, M. N., Chowdhury, M. S. N., Sarker, S., Alamgir, M., … Chowdhury, S. (2021). Seaweeds farming for sustainable development goals and blue economy in Bangladesh. Marine Policy, 128(1), 104469. https://doi.org/10.1016/j.marpol.2021.104469
28. Hosseini-Motlagh, S.-M., Nami, N., & Farshadfar, Z. (2020). Collection disruption management and channel coordination in a socially concerned closed-loop supply chain: A game theory approach. Journal of Cleaner Production, 276(1), 124173. https://doi.org/10.1016/j.jclepro.2020.124173
29. Hu, Y., Scherngell, T., Man, S. N., & Wang, Y. (2013). Is the United States Still Dominant in the Global Pharmaceutical Innovation Network? PLoS ONE, 8(11), e77247. https://doi.org/10.1371/journal.pone.0077247
30. Ibrahim, M. I. M., & Wertheimer, A. I. (2018). Introduction. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries, 1–11. https://doi.org/10.1016/b978-0-12-811228-1.00001-7
31. Janes, K. A., Chandran, P. L., Ford, R. M., Lazzara, M. J., Papin, J. A., Peirce, S. M., … Lauffenburger, D. A. (2017). An engineering design approach to systems biology. Integrative Biology, 9(7), 574–583. https://doi.org/10.1039/c7ib00014f
32. Kohli, M., & Gill, S. (2019). Impact of family involvement on strategy and CEO compensation. Journal of Family Business Management, 10(3), 189–212. https://doi.org/10.1108/jfbm-09-2019-0060
33. Kumar, A., Zavadskas, E. K., Mangla, S. K., Agrawal, V., Sharma, K., & Gupta, D. (2018). When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry. International Journal of Production Research, 1–23. https://doi.org/10.1080/00207543.2018.1543969
34. Lakner, Z., Kiss, A., Popp, J., Zéman, Z., Máté, D., & Oláh, J. (2019). From Basic Research to Competitiveness: An Econometric Analysis of the Global Pharmaceutical Sector. Sustainability, 11(11), 3125. https://doi.org/10.3390/su11113125
35. Limas Suárez, S. J. (2018). El sector farmacéutico, eje de desarrollo estratégico. Una perspectiva desde el ámbito local. Innovar, 28(69), 149–174. https://doi.org/10.15446/innovar.v28n69.71733
36. Lucarini, M., Durazzo, A., Romani, A., Campo, M., Lombardi-Boccia, G., & Cecchini, F. (2018). Bio-Based Compounds from Grape Seeds: A Biorefinery Approach. Molecules, 23(8), 1888. https://doi.org/10.3390/molecules23081888
37. Marques, C. M., Moniz, S., de Sousa, J. P., Barbosa-Povoa, A. P., & Reklaitis, G. (2020). Decision-support challenges in the chemical-pharmaceutical industry: Findings and future research directions. Computers & Chemical Engineering, 134(1), 106672. https://doi.org/10.1016/j.compchemeng.2019.106672
38. McKinlay, J. B. (Ed.). (2022). Issues in the political economy of health care (Vol. 25). Routledge. https://books.google.es/books?id=gAJlEAAAQBAJ&lr=&hl=es&source=gbs_navlinks_s
39. Milanesi, M., Runfola, A., & Guercini, S. (2020). Pharmaceutical industry riding the wave of sustainability: Review and opportunities for future research. Journal of cleaner production, 261(1), 121204. https://doi.org/10.1016/j.jclepro.2020.121204
40. Monteiro, A. R., Battisti, A. P., Valencia, G. A., & de Andrade, C. J. (2023). The production of high-added-value bioproducts from non-conventional biomasses: An overview. Biomass, 3(2), 123-137. https://doi.org/10.3390/biomass3020009
41. Mussagy, C. U., & Dufossé, L. (2023). A review of natural astaxanthin production in a circular bioeconomy context using Paracoccus carotinifaciens. Bioresource Technology, 369(1), 128499. https://doi.org/10.1016/j.biortech.2022.128499
42. Naeem, M. Y., Corbo, F., Crupi, P., & Clodoveo, M. L. (2023). Hemp: An alternative source for various industries and an emerging tool for functional food and pharmaceutical sectors. Processes, 11(3), 718. https://doi.org/10.3390/pr11030718
43. Nguyen, T. A., Vitry, A., & Roughead, E. E. (2017). Pharmaceutical Policy in Vietnam. Pharmaceutical Policy in Countries with Developing Healthcare Systems, 75–94. https://doi.org/10.1007/978-3-319-51673-8_5
44. Niebles-Nunez, W., Ramirez, J., & Garcia-Tirado, J. (2022). International Trade between Colombia and Asia in the Framework of Logistics Processes: A Bibliometric Review. Journal of Distribution Science, 20(10), 39-50. https://n9.cl/z77hed
45. Pai, S., Hebbar, A., & Selvaraj, S. (2022). A critical look at challenges and future scopes of bioactive compounds and their incorporations in the food, energy, and pharmaceutical sector. Environmental Science and Pollution Research, 29(24), 35518-35541. https://doi.org/10.1007/s11356-022-19423-4
46. Purkayastha, S., Manolova, T. S., & Edelman, L. F. (2015). Business Group Effects on the Innovation-Internationalization Relationship: Evidence from the Indian Pharmaceutical Sector. Advances in International Management, 379–402. https://doi.org/10.1108/s1571-502720150000028017
47. Ramirez, J., Gallego, G., Ez, W. N. N. N., & Tirado, J. G. (2023). Blockchain Technology for Sustainable Supply Chains: A Bibliometric Study. Journal of Distribution Science, 21(6), 119-129. https://doi.org/10.15722/jds.21.06.202306.119
48. Ramírez-Duran, J. A., Niebles-Núñez, W., & García-Tirado, J. (2023). Aplicaciones bibliométricas del estudio del capital intelectual dentro de las instituciones de educación superior desde un enfoque sostenible. Saber, Ciencia y Libertad, 18(1). https://n9.cl/2ofg4
49. Ramy, A., Af Ragab, M., & Arisha, A. (2020). Knowledge management in the pharmaceutical industry between academic research and industry regulations. Knowledge Management Research & Practice, 1–17. https://doi.org/10.1080/14778238.2020.1767517
50. Romani, A., Campo, M., Urciuoli, S., Marrone, G., Noce, A., & Bernini, R. (2020). An Industrial and Sustainable Platform for the Production of Bioactive Micronized Powders and Extracts Enriched in Polyphenols From Olea europaea L. and Vitis vinifera L. Wastes. Frontiers in Nutrition, 7(1). https://doi.org/10.3389/fnut.2020.00120
51. Sabat, K. C., Bhattacharyya, S. S., & Krishnamoorthy, B. (2022). Circular economy in pharmaceutical industry through the lens of stimulus organism response theory. European Business Review, 34(6), 936-964. https://doi.org/10.1108/EBR-02-2022-0037
52. Scott, P., & Walker, J. T. (2017). Retailing under resale price maintenance: Economies of scale and scope, and firm strategic response, in the inter-war British retail pharmacy sector. Business History, 60(6), 807–832. https://doi.org/10.1080/00076791.2017.1340455
53. Sharma, M., Sehrawat, R., Giannakis, M., & Dwivedi, Y. K. (2023). Learnings from Industry 4.0 for transitioning towards Industry 4.0+: challenges and solutions for Indian pharmaceutical sector. Annals of operations research, 1-28. https://doi.org/10.1007/s10479-023-05391-6
54. Sharma, S., & Dharni, K. (2017). Intellectual capital disclosures in an emerging economy: status and trends. Journal of Intellectual Capital, 18(4), 868–883. https://doi.org/10.1108/jic-09-2016-0092
55. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., ... & Yang, C. (2021). Drug shortage: causes, impact, and mitigation strategies. Frontiers in pharmacology, 12(1), 693426. https://doi.org/10.3389/fphar.2021.693426
56. Silva, B. C., & Moreira, A. C. (2022). Entrepreneurship and the gig economy: A bibliometric analysis. Cuadernos de Gestión, 22(2), 23-44. http://hdl.handle.net/10810/56543
57. Stek, P. E., & van Geenhuizen, M. S. (2016). The influence of international research interaction on national innovation performance: A bibliometric approach. Technological Forecasting and Social Change, 110(1), 61–70. https://doi.org/10.1016/j.techfore.2015.09.017
58. Subramanian, D., & Zimmermann, B. (2013). Training and capabilities in French firms. International Journal of Manpower, 34(4), 326–344. https://doi.org/10.1108/ijm-05-2013-0093
59. Sun, P., Qu, Z., & Liao, Z. (2018). How and When Do Subnational Institutions Matter for R&D Investment? Evidence From the Chinese Pharmaceutical Sector. IEEE Transactions on Engineering Management, 65(3), 379–391. https://doi.org/10.1109/tem.2018.2793215
60. Sussex, J., Feng, Y., Mestre-Ferrandiz, J., Pistollato, M., Hafner, M., Burridge, P., & Grant, J. (2016). Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom. BMC Medicine, 14(1). https://doi.org/10.1186/s12916-016-0564-z
61. Tennent, K. D., & Gillett, A. G. (2023). How to research in an archive. Handbook of historical methods for management. Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing, 104-120. https://n9.cl/x1z6y
62. Tripathy, S., & Prajapati, V. (2014). Mergers and acquisitions: Trends in Indian pharmaceutical industry. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 14(4), 182–190. https://doi.org/10.1177/1745790415577854
63. Vecino, X., Reig, M., Valderrama, C., & Cortina, J. L. (2021). Ion-Exchange Technology for Lactic Acid Recovery in Downstream Processing: Equilibrium and Kinetic Parameters. Water, 13(11), 1572. https://doi.org/10.3390/w13111572
64. Weqar, F., & Haque, S. I. (2022). The influence of intellectual capital on Indian firms' financial performance. International Journal of Learning and Intellectual Capital, 19(2), 169-188. https://doi.org/10.1504/IJLIC.2022.121249
65. Wouters, O. J., McKee, M., & Luyten, J. (2020). Estimated research and development investment needed to bring a new medicine to market, 2009-2018. Jama, 323(9), 844-853. https://doi.org/10.1001/jama.2020.1166
66. Yadav, P., & Smith, L. (2014). Pharmaceutical Company Strategies and Distribution Systems in Emerging Markets. Encyclopedia of Health Economics, 1–8. https://doi.org/10.1016/b978-0-12-375678-7.01218-9
Article Sidebar
Published
May 13, 2023
Article Details
How to Cite
John Arturo Buelvas Parra, William Niebles Nuñez, & León Arango Buelvas. (2023). PHARMACEUTICAL SECTOR AND ECONOMY: A BIBLIOMETRIC ANALYSIS. Journal of Population Therapeutics and Clinical Pharmacology, 30(10), 642–655. https://doi.org/10.53555/jptcp.v30i10.6703
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
John Arturo Buelvas Parra
Universidad de Sucre (Colombia)
William Niebles Nuñez
Universidad de Sucre (Colombia)
León Arango Buelvas
Universidad de Sucre (Colombia)